The PCV15/PCV20 Study

👤 2 months to 2 months 2 weeks
📅 5 or 6 visits over 11 months
💉 2 or 3 vaccinations along with other routine vaccinations

🧬 A study which will guide decisions on future changes to the routine UK immunisation schedule
ⓘ Study visits will be in the participant’s own homes.

Participants will have five or 6 study visits at home or at the trial site.  They will receive two doses of either PCV15, PCV20, or PCV13, or three doses of PCV20, as well as all their routine vaccines. These vaccines protect against 15, 20, or 13 strains of Pneumococcal disease, which is a serious bacterial infection.

Blood tests, to measure the immune response to the vaccines, will be taken at two of the visits. Local anaesthetic cream is used to numb the skin. Taking part in this study is voluntary and participants can withdraw at any time.

If you would like any further information, please visit the site websites below:

The following sites are currently recruiting - please select the site below:

OXFORD VACCINE GROUP (THAMES VALLEY AREA)

ST. GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST AND ST. GEORGE’S VACCINE INSTITUTE (SOUTH WEST LONDON AREA)

BRISTOL VACCINE CENTRE FOR CHILDREN (BRISTOL AREA)

THE UNIVERSITY OF NOTTINGHAM HEALTH SERVICE (NOTTINGHAM AREA)

UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST (SOUTHAMPTON AREA)